VENUSREM — Venus Remedies Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹16.56bn
- IN₹15.76bn
- IN₹7.70bn
Annual cashflow statement for Venus Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 364 | 379 | 446 | 619 | 1,342 |
| Depreciation | |||||
| Non-Cash Items | -63.1 | -89.7 | -62.1 | -75.4 | -73 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -226 | -246 | -276 | 96.1 | 32.5 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 410 | 366 | 373 | 864 | 1,558 |
| Capital Expenditures | -137 | -78.2 | -135 | -181 | -377 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -29.2 | -430 | 63.1 | -582 | -1,439 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -166 | -508 | -72.1 | -762 | -1,816 |
| Financing Cash Flow Items | -4.62 | -1.18 | -0.936 | -0.654 | -5.85 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -94.8 | -5.67 | -10.8 | -10.2 | -31.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 144 | -220 | 277 | 85.7 | -324 |